↓ Skip to main content

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

Overview of attention for article published in BMC Psychiatry, August 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
65 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
Published in
BMC Psychiatry, August 2011
DOI 10.1186/1471-244x-11-145
Pubmed ID
Authors

Eirik Kjelby, Hugo A Jørgensen, Rune A Kroken, Else-Marie Løberg, Erik Johnsen

Abstract

Efficacy studies indicate anti-depressive effects of at least some second generation antipsychotics (SGAs). The Bergen Psychosis Project (BPP) is a 24-month, pragmatic, industry-independent, randomized, head-to-head comparison of olanzapine, quetiapine, risperidone and ziprasidone in patients acutely admitted with psychosis. The aim of the study is to investigate whether differential anti-depressive effectiveness exists among SGAs in a clinically relevant sample of patients acutely admitted with psychosis.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Israel 1 2%
United States 1 2%
Canada 1 2%
Unknown 61 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 14%
Student > Doctoral Student 8 12%
Student > Ph. D. Student 7 11%
Student > Bachelor 7 11%
Student > Master 7 11%
Other 17 26%
Unknown 10 15%
Readers by discipline Count As %
Medicine and Dentistry 21 32%
Psychology 9 14%
Pharmacology, Toxicology and Pharmaceutical Science 8 12%
Agricultural and Biological Sciences 5 8%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 3 5%
Unknown 17 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2015.
All research outputs
#6,888,555
of 12,409,853 outputs
Outputs from BMC Psychiatry
#1,755
of 2,890 outputs
Outputs of similar age
#50,455
of 90,823 outputs
Outputs of similar age from BMC Psychiatry
#9
of 22 outputs
Altmetric has tracked 12,409,853 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,890 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,823 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.